Embryo size is a critical trait determining not only grain yield but also the nutrition of the maize kernel.Up to the present,only a few genes have been characterized affecting the maize embryo/kernel ratio.Here,we id...Embryo size is a critical trait determining not only grain yield but also the nutrition of the maize kernel.Up to the present,only a few genes have been characterized affecting the maize embryo/kernel ratio.Here,we identify 63 genes significantly associated with maize embryo/kernel weight ratio using a genome-wide association study(GWAS).The peak GWAS signal shows that the natural variation in Zea mays COMPACT PLANT2(CT2),encoding the heterotrimeric G proteinαsubunit,is significantly associated with the Embryo/Kernel Weight Ratio(EKWR).Further analyses show that a missense mutation of CT2 increases its enzyme activity and associates with EKWR.The function of CT2 on affecting embryo/kernel weight ratio is further validated by the characterization of two ct2 mutants,for which EKWR is significantly decreased.Subsequently,the key downstream genes of CT2 are identified by combining the differential expression analysis of the ct2 mutant and quantitative trait transcript analysis in the GWAS population.In addition,the allele frequency spectrum shows that CT2 was under selective pressure during maize domestication.This study provides important genetic insights into the natural variation of maize embryo/kernel weight ratio,which could be applied in future maize breeding programs to improve grain yield and nutritional content.展开更多
Objective:Robot-assisted partial nephrectomy(RAPN)has become widely used for treatment of renal cell carcinoma and it is expanding in the field of complex renal masses.The aim of this systematic review was to analyze ...Objective:Robot-assisted partial nephrectomy(RAPN)has become widely used for treatment of renal cell carcinoma and it is expanding in the field of complex renal masses.The aim of this systematic review was to analyze outcomes of RAPN for completely endophytic renal masses,large tumors(cT2-T3),renal cell carcinoma in solitary kidney,recurrent tumors,completely endophytic and hilar masses,and simultaneous and multiple tumors.Methods:A comprehensive search in the PubMed,Scopus,Web of Science,and Cochrane Central Register of Controlled Trials databases was performed in December 2022 for English language papers.The primary endpoint was to evaluate the role of RAPN in the setting of each category of complex renal masses considered.The secondary endpoint was to evaluate the surgical and functional outcomes.Results:After screening 1250 records,43 full-text manuscripts were selected,comprising over 8500 patients.Twelve and thirteen studies reported data for endophytic and hilar renal masses,respectively.Five and three studies reported outcomes for cT2-T3 and solitary kidney patients,respectively.Four studies focused on redo-RAPN for recurrent tumors.Two studies investigated simultaneous bilateral renal masses and five reports focused on multiple tumor excision in ipsilateral kidney.Conclusion:Over the past decade,evidence supporting the use of RAPN for the most challenging nephron-sparing surgery indications has continuously grown.Although limitations remain including study design and lack of detailed long-term functional and oncological outcomes,the adoption of RAPN for the included advanced indications is associated with favorable surgical outcomes with good preservation of renal function without compromising the oncological result.Certainly,a higher likelihood of complication might be expected when facing extremely challenging cases.However,none of these indications should be considered per se an exclusion criterion for performing RAPN.Ultimately,a risk-adapted approach should be employed.展开更多
基金supported by National Key Research and Development Program of China(2023YFF1000400)National Natural Science Foundation of China(32101693)+2 种基金Key Research and Development Program of Shaanxi(2021ZDLNY01-06)Agricultural Science and Technology Innovation Program of CAAS(CAAS-ZDRW202004)supported by Hatch project(1019088).
文摘Embryo size is a critical trait determining not only grain yield but also the nutrition of the maize kernel.Up to the present,only a few genes have been characterized affecting the maize embryo/kernel ratio.Here,we identify 63 genes significantly associated with maize embryo/kernel weight ratio using a genome-wide association study(GWAS).The peak GWAS signal shows that the natural variation in Zea mays COMPACT PLANT2(CT2),encoding the heterotrimeric G proteinαsubunit,is significantly associated with the Embryo/Kernel Weight Ratio(EKWR).Further analyses show that a missense mutation of CT2 increases its enzyme activity and associates with EKWR.The function of CT2 on affecting embryo/kernel weight ratio is further validated by the characterization of two ct2 mutants,for which EKWR is significantly decreased.Subsequently,the key downstream genes of CT2 are identified by combining the differential expression analysis of the ct2 mutant and quantitative trait transcript analysis in the GWAS population.In addition,the allele frequency spectrum shows that CT2 was under selective pressure during maize domestication.This study provides important genetic insights into the natural variation of maize embryo/kernel weight ratio,which could be applied in future maize breeding programs to improve grain yield and nutritional content.
文摘Objective:Robot-assisted partial nephrectomy(RAPN)has become widely used for treatment of renal cell carcinoma and it is expanding in the field of complex renal masses.The aim of this systematic review was to analyze outcomes of RAPN for completely endophytic renal masses,large tumors(cT2-T3),renal cell carcinoma in solitary kidney,recurrent tumors,completely endophytic and hilar masses,and simultaneous and multiple tumors.Methods:A comprehensive search in the PubMed,Scopus,Web of Science,and Cochrane Central Register of Controlled Trials databases was performed in December 2022 for English language papers.The primary endpoint was to evaluate the role of RAPN in the setting of each category of complex renal masses considered.The secondary endpoint was to evaluate the surgical and functional outcomes.Results:After screening 1250 records,43 full-text manuscripts were selected,comprising over 8500 patients.Twelve and thirteen studies reported data for endophytic and hilar renal masses,respectively.Five and three studies reported outcomes for cT2-T3 and solitary kidney patients,respectively.Four studies focused on redo-RAPN for recurrent tumors.Two studies investigated simultaneous bilateral renal masses and five reports focused on multiple tumor excision in ipsilateral kidney.Conclusion:Over the past decade,evidence supporting the use of RAPN for the most challenging nephron-sparing surgery indications has continuously grown.Although limitations remain including study design and lack of detailed long-term functional and oncological outcomes,the adoption of RAPN for the included advanced indications is associated with favorable surgical outcomes with good preservation of renal function without compromising the oncological result.Certainly,a higher likelihood of complication might be expected when facing extremely challenging cases.However,none of these indications should be considered per se an exclusion criterion for performing RAPN.Ultimately,a risk-adapted approach should be employed.
